We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

POC Hemostasis System Could Help Prevent Maternal Deaths

By LabMedica International staff writers
Posted on 27 Dec 2024
Print article
Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)
Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)

Postpartum hemorrhage (PPH), which refers to severe bleeding following childbirth, is the leading cause of maternal deaths globally. Every year, about 14 million women experience PPH, and approximately 70,000 die as a result. This issue is not limited to developing countries, as the United States reports 21.1 deaths per 100,000 live births, nearly double the average in countries belonging to the Organization for Economic Cooperation and Development (OECD), with over 10% of maternal deaths attributed to excessive bleeding. Now, new research is exploring how a novel hemostasis system could potentially improve the management of peripartum bleeding in obstetric patients.

HemoSonics (Durham, NC, USA) is researching the role of its Quantra Hemostasis System in enhancing the management of peripartum bleeding. The system includes the Quantra Hemostasis Analyzer, equipped with QPlus and QStat Cartridges, which provide clinicians with valuable data to guide patient-centered decisions regarding bleeding control, improving care and optimizing blood product use. The Quantra System utilizes SEER Sonorheometry (Sonic Estimation of Elasticity via Resonance), a proprietary ultrasound technology that assesses the coagulation properties of whole blood samples.

This system is easy to maintain, simple to operate and interpret, and offers rapid, comprehensive whole-blood coagulation analysis in under 15 minutes, whether at the point of care or in laboratory settings. The Quantra System is FDA-cleared for use in cardiovascular surgeries, trauma, liver transplants, and major orthopedic procedures. It helps hospitals standardize their viscoelastic testing processes in a clinically efficient and operationally effective manner. Recently, HemoSonics was selected as one of the final winners for the RADx Tech for Maternal Health Challenge from over 80 submissions for efforts to improve postpartum maternal health and health equity with innovative diagnostic tools.

“It is a tremendous validation to receive the RADx award and recognition from NIH to help support research for how the Quantra Hemostasis System may help obstetric patients,” said HemoSonics’ President and CEO Bob Roda. “Along with the other winners, HemoSonics will work tirelessly to advance technologies that help women have safe and healthy deliveries, wherever they may live, and to improve overall maternal health.”

Related Links:
HemoSonics

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.